IRCT20200504047298N1已完成3 期
Evaluation of Atazanavir/Ritonavir effect on COViD-19 patients treatment in comparison with Lopinavir / Ritonavir
Alborz University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 80 years（—）
- 性别
- All
入选标准
- •all COViD-19 patients aged between 20-80
排除标准
- •low blood pressure
- •Low mental status
- •poor collaboration
研究者
相似试验
已完成
不适用
Post-prandial lipid effects of ritonavir-boosted atazanavir vs ritonavir-boosted darunavir in HIV-uninfected adultsACTRN12610000917033St vincents Hospital20
进行中（未招募）
不适用
Efficacy of atazanavir/ritonavir monotherapy as maintenance in patients with viral suppression. Randomized, open label non inferiority trial. (MODAt STUDY) - NDEUCTR2010-020442-10-ITFONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
已完成
3 期
Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral SuppressionHIV-1 InfectionNCT01511809IRCCS San Raffaele117
已完成
4 期
Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)HIV InfectionsNCT00552240Boehringer Ingelheim154
已完成
3 期
Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIVHIV InfectionsNCT00035932Bristol-Myers Squibb571